Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner

Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells

(2013) B. Jammart et al.   JOURNAL OF VIROLOGY

Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies

(2013) Marion Sourisseau et al.   PLoS Pathogens

IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease

(2013) Amina A. Negash et al.   PLoS Pathogens

Hepatoma polarization limits CD81 and hepatitis C virus dynamics

(2012) H. J. Harris et al.   CELLULAR MICROBIOLOGY

Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

(2012) Evaggelia Liaskou et al.   HEPATOLOGY

Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway

(2012) Loredana Petecchia et al.   LABORATORY INVESTIGATION

Hepatitis C virus entry: beyond receptors

(2012) Luke W. Meredith et al.   REVIEWS IN MEDICAL VIROLOGY

Hepatitis C virus host cell entry

(2012) Alexander Ploss et al.   Current Opinion in Virology

Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

(2011) Netanya G. Sandler et al.   GASTROENTEROLOGY

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus

(2011) Jean-Michel Pawlotsky   HEPATOLOGY

HIV-1 Coinfection and Morphine Coexposure Severely Dysregulate Hepatitis C Virus-Induced Hepatic Proinflammatory Cytokine Release and Free Radical Production: Increased Pathogenesis Coincides with Uncoordinated Host Defenses

(2011) N. El-Hage et al.   JOURNAL OF VIROLOGY

New direct-acting antivirals' combination for the treatment of chronic hepatitis C

(2011) Tarik Asselah et al.   LIVER INTERNATIONAL

Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review

(2011) A. M. G. Brunasso et al.   RHEUMATOLOGY

Tumour Necrosis Factor Gene Polymorphism and Disease Prevalence

(2011) T. Qidwai et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells

(2011) Verena Lütschg et al.   Nature Communications

The role of intestinal endotoxin in liver injury: A long and evolving history

(2010) James P. Nolan   HEPATOLOGY

Alcoholic liver disease and the gut-liver axis

(2010) Gyongyi Szabo   WORLD JOURNAL OF GASTROENTEROLOGY

The tight junction in inflammatory disease: communication breakdown

(2009) Karen L Edelblum et al.   CURRENT OPINION IN PHARMACOLOGY

Toll-like receptors as targets in chronic liver diseases

(2009) A Mencin et al.   GUT

Inhibition of Hepatitis C Virus Infection by Interferon-γ Through Downregulating Claudin-1

(2009) Xin Wei et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles

(2009) F.-L. Cosset et al.   JOURNAL OF VIROLOGY

Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells

(2009) C. J. Mee et al.   JOURNAL OF VIROLOGY

Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

(2008) Ashwin Balagopal et al.   GASTROENTEROLOGY

Macrophages in Hepatitis B and Hepatitis C Virus Infections

(2008) M. Heydtmann   JOURNAL OF VIROLOGY